Our Mission
CAR-T cell therapy is a rapidly evolving treatment, primarily used for blood diseases. As of 2025, clinical trials worldwide are working to expand its use to earlier stages of disease, more blood conditions, autoimmune diseases, and solid tumors.
The field of CAR-T therapy is constantly evolving, with new treatment options emerging as research advances. At the same time, patients facing disease recurrence have only a short window to begin treatment. Navigating these rapid developments can be overwhelming. Our mission is to help patients find the best CAR-T therapy for their condition, ensuring they receive timely and effective care.
Who We Are
Mash Medical Ltd. has been a leader in medical tourism since 2009, connecting patients with top hospitals worldwide. We have assisted over 30,000 patients across various medical fields.
In 2020, we launched a specialized CAR-T division to help patients worldwide access this cutting-edge treatment. With our expertise, we simplify the process, guiding patients to the best available options.
Partnership certificates:
Mash Medical's management team:
Tanya Preminger
CEO
Michael As
Senior Dr. Consultant
Emi Aziel
Head of Finance
Mary Scripnic
Head of Marketing
GLOBAL HEALTHCARE ACCREDITATION >>
Interview with our CEO in World Care Magazine, featuring the Middle East's most empowering women redefining healthcare.
Read article>
The company is registered in the Israeli governmental medical travel agents directory.
